Please Wait...

  • +91 22 2783 1455

  • Product background
    DEFLASTERONE 6 (Deflazacort Tablets 6 mg)

WARNING: CAUTION : PLEASE NOTE :
The content or product detailing is not intended to replace advice from your prescribing doctor or healthcare professional. Lavina Pharma is not responsible for such actions by consumers. For any further information about the product please contact +91 22 2783 1455 and we can provide you the details.

Deflazacort is a glucocorticoid. Its anti-inflammatory and immunosuppressive effects are used in

treating a variety of diseases and are comparable to other anti-inflammatory steroids.  

DEFLASTERONE 6 is a corticosteroid medication containing 6 mg of deflazacort, designed to reduce inflammation and suppress the immune response.

It is commonly used to treat various conditions, including autoimmune disorders, allergies, and certain types of arthritis. Deflazacort is known for its favorable

side effect profile compared to other corticosteroids, making it suitable for long-term use. The tablet is typically taken orally, with or without food, and is available in a convenient dosing format.

Patients should follow their healthcare provider's guidance to ensure effective and safe treatment.


COMPOSITION

Each uncoated tablet contains:

Deflazacort …….6 mg

Excipients……………...  q.s 

         Oral

DOSAGE

As directed by the physician.

SIDE EFFECT

·         Weight gain

·         Suppression of the hypothalamic-pituitary-adrenal axis

·         Recurrence of dormant tuberculosis

·         Osteoporosis, vertebral and long bone fractures

·         Menstrual irregularity

·         Headache, vertigo





PRECAUTION

Complications of glucocorticoid therapy are dependent on dose and duration of therapy, the

lowest possible dose must be given, and a risk/benefit decision must be made as to whether

intermittent therapy should be used. Undesirable effect may be minimised by using the lowest

effective dose for the minimum period, and by administering the daily requirement as a single

morning dose or alternate days. Frequent patient review is required to appropriately titrate the

dose against disease activity.




PRESENTATION

3 X 10 Tablets.